Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NEO · against 596 other Healthcare companies listed in US-listed
Ranked #407 of 597 · scores higher than 32% of peers · safety percentile 23
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)59 peers with a safety percentile of 20–29, including NEO · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | NEO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.57× | 0.23× | 35% | 33% | |
| BetaLower is better · 556 reported | 1.78 | 0.95 | 16% | 33% | |
| Current ratioHigher is better · 600 reported | 3.60× | 3.91× | 48% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 403 | 12M USD | 24 | 38 | |
| 404 | 116.9B USD | 23 | 47 | |
| 405 | 3.4B USD | 23 | 17 | |
| 406 | 4.0B USD | 23 | 56 | |
| 407 | 2.2B USD | 23 | 36 | |
| 408 | 52.9B USD | 23 | 57 | |
| 409 | 1.2B USD | 23 | 42 | |
| 410 | 4.8B USD | 22 | 52 | |
| 411 | 1.4B USD | 22 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score